Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (5y) (2023 - 2026)
Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Arcturus Therapeutics Holdings | 163.70 Mn | -47.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.22% |
| Dec 31, 2025 | -15.20% |
| Sep 30, 2025 | -15.93% |
| Jun 30, 2025 | -17.79% |
| Mar 31, 2025 | -11.06% |
| Dec 31, 2024 | 44.38% |
| Sep 30, 2024 | -26.68% |
| Jun 30, 2024 | -38.48% |
| Mar 31, 2024 | 8.04% |
| Dec 31, 2023 | -38.85% |
| Sep 30, 2023 | -68.15% |